StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for NWBO yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $0.28 | $0.25 | -10.67% | 2.7M |
| 05-15 | $0.26 | $0.25 | -2.43% | 3.0M |
| 05-18 | $0.25 | $0.25 | -1.19% | 2.6M |
| 05-19 | $0.25 | $0.25 | +0.72% | 3.7M |
| 05-20 | $0.26 | $0.25 | -3.59% | 1.2M |
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
NORTHWEST BIOTHRPUTCS INC
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $494.00K | $1.38M | $706.00K | $506.00K |
Operating Income | $-10.90M | $-59.91M | $-46.41M | $-32.09M |
Net Income | $-3.07M | $-60.16M | $-61.55M | $-34.72M |
EPS (Diluted) | $0.00 | $-0.04 | $-0.04 | $-0.03 |
Total Assets | $80.05M | $81.29M | $30.61M | $29.55M |
Total Liabilities | $118.11M | $128.86M | $125.86M | $116.18M |
Cash & Equivalents | $1.79M | $3.04M | $4.56M | $4.32M |
Free Cash Flow OCF − CapEx | $-12.64M | $-46.27M | $-30.60M | $-16.50M |
Shares Outstanding | 1.61B | 1.56B | 1.52B | 1.46B |